Cutaneous sarcoidosis due to immune‐checkpoint inhibition and exacerbated by a novel BRAF dimerization inhibitor

• المؤلفون الرئيسيون: J. P. Pham (مؤلف), P. Star (مؤلف), S. Wong (مؤلف), D. L. Damian (مؤلف), R. P. M. Saw (مؤلف), M. J. Whitfeld (مؤلف), A. M. Menzies (مؤلف), A. M. Joshua (مؤلف), A. Smith (مؤلف)
• التنسيق: كتاب
• منشور في: Wiley, 2021-12-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Abstract Sarcoidosis is a non‐infective granulomatous disorder of unknown aetiology, with cutaneous involvement affecting up to 30% of patients. Drug‐induced sarcoidosis has been reported secondary to modern melanoma therapies including immune‐checkpoint inhibitors and first generation BRAF inhibito...